BCI With 40Hz Stimulation in Alzheimer's Disease
Recruiting
N/A
Interventional Study
Alzheimer Dementia (AD)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 50 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 90 (estimated)
- Sponsor
- Ruijin Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to evaluate the efficacy and safety of non-invasive brain-computer interface (BCI) neuromodulation technique combined with 40Hz audio-visual stimulation on cognitive function in patients with Alzheimer's disease (AD). This is a single-center, randomized, double-blind, sham-controlled trial. A total of 90 participants with Aβ-PET positive AD diagnosed according to NIA-AA criteria wi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Diagnosis of Alzheimer's disease according to the NIA-AA 2018 diagnostic criteria.
2. Age between 50 and 80 years, inclusive.
3. Positive Aβ-PET scan result.
4. Has a stable caregiver who can assist with daily stimulation intervention.
5. Chronic medical conditions stable for…
Contacts